Recruiting studies: Skin Cancer Face

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

An Open-Label, Two-Cohort, Pharmacokinetic Study in a Maximal Use Setting for Patients With Actinic Keratosis on the Upp
Phase 1 · 1 location(s) · Sun Pharmaceutical Industries Limited · NCT07729579 The Effect of Topical Imipramine on Photodynamic Therapy-Mediated Immunosuppression on Forearms or Face on US Veterans
Phase 2 · 1 location(s) · VA Office of Research and Development · NCT06778434 Study of Reformulated Levulan Kerastick Plus PDT for Actinic Keratosis on Face and Scalp
Phase 3 · 10 location(s) · Sun Pharmaceutical Industries, Inc. · NCT07144345 Comparing Numbing Techniques in Mohs Micrographic Surgery
NA · 1 location(s) · Abramson Cancer Center at Penn Medicine · NCT07222241 Phase 3 - Evaluation of Veregen® 10% Ointment as New Herbal Topical Treatment for Actinic Keratosis
Phase 3 · 1 location(s) · Aresus Pharma GmbH · NCT07137819 Topical Tretinoin Prophylaxis for Anti-EGFR Induced Skin Toxicity in Patients With Solid Tumors
Phase 2 · 1 location(s) · University of Utah · NCT06358677 Rare Disease Patient Registry & Natural History Study - Coordination of Rare Diseases at Sanford
Phase N/A · 2 location(s) · Sanford Health · NCT01793168 Nasal Reconstruction FACE-Q : French Validation of the Nasal Reconstruction FACE-Q Questionnaire for Reconstruction/Reha
Phase N/A · 9 location(s) · Hôpital NOVO · NCT07257094 Evaluating the Use of Photodynamic Therapy to Treat Facial Cutaneous Squamous Cell Carcinoma in Situ (SCCis)
Phase 2 · 1 location(s) · The Center for Clinical and Cosmetic Research · NCT06577311 Outcomes Associated With Tirbanibulin for Large Field Application on the Face in the U.S (CLEAR)
Phase N/A · 2 location(s) · Avant Health LLC · NCT07657988 Tranexamic Acid in Nasal Mohs Reconstruction
Phase 2 · 1 location(s) · Vanderbilt University Medical Center · NCT06057675 Alpha Radiation Emitters Device (DaRT) for the Treatment of of Malignant Cutaneous Tumors
NA · 2 location(s) · Alpha Tau Medical LTD. · NCT04068155

Look up another condition

Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.